No Data
D.A. Davidson Maintains Medifast(MED.US) With Sell Rating, Maintains Target Price $17.5
D.A. Davidson analyst Linda Bolton Weiser maintains $Medifast(MED.US)$ with a sell rating, and maintains the target price at $17.5.According to TipRanks data, the analyst has a success rate of 44.8%
D.A. Davidson Sticks to Its Sell Rating for Medifast (MED)
Medifast (MED) Lags Industry in 3 Months: How to Play Ahead?
Medifast, Inc.'s (NYSE:MED) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Personal Care Stocks Q1 Teardown: Medifast (NYSE:MED) Vs The Rest
Medifast Named as One of The "Best Companies To Work For" by U.S. News & World Report
Company recognized as one of the best employers in the food and drink industry for 2024-2025 Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution